BETA SAÚDE
Cefdaloxime
Texto da Wikipédia (en), licença CC BY-SA. O BETARUBI mostra o verbete inteiro nesta página — a leitura não continua fora do site.
 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H15N5O6S2 |
| Molar mass | 413.42 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Cefdaloxime (INN) is a third-generation cephalosporin antibiotic.[1] Developed in the late 1980's by Hoechst-Roussel Pharmaceuticals Inc.,[2] it was never brought to market.[3]
References
- ↑ Sader HS, Runyon BA, Erwin ME, Jones RN (February 1995). "Antimicrobial activity of 11 newer and investigational drugs tested against aerobic isolates from spontaneous bacterial peritonitis". Diagnostic Microbiology and Infectious Disease. 21 (2): 105–110. doi:10.1016/0732-8893(94)00148-p. PMID 7628189.
- ↑ Jones RN, Erwin ME (May 1992). "Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin". Journal of Clinical Microbiology. 30 (5): 1297–1300. doi:10.1128/jcm.30.5.1297-1300.1992. PMC 265269. PMID 1583135.
- ↑ Zagursky RJ, Pichichero ME (2018). "Cross-reactivity in β-Lactam Allergy". The Journal of Allergy and Clinical Immunology. In Practice. 6 (1): 72–81.e1. doi:10.1016/j.jaip.2017.08.027. PMID 29017833.
 | This systemic antibiotic-related article is a stub. You can help Wikipedia by adding missing information. |